Healthcare >> CEO Interviews >> November 5, 2002
KEVIN P. CORCORAN was appointed President and Chief Executive
Officer of Lynx Therapeutics, Inc., in June 2002. From January
1999 to June 2002 he served as Vice President, Operations with
direct responsibility for Process Development, Technology
Development, Engineering, Chemistry, Informatics, MIS and
Facilities. Mr. Corcoran joined Lynx in September 1995 as Staff
Software Engineer and was a founding member of the MPSS
development team. He was initially responsible for the design and
development of the DNA basecalling system used to produce MPSS
expression information. Prior to joining Lynx, Mr. Corcoran held
various managerial positions with Applied Biosystems. His most
recent role at Applied Biosystems was Group Leader for Genetic
Analysis software, with development responsibility for automated
DNA. sequencers and related analysis software. Mr. Corcoran was
the original author of the GeneScan_ analysis software developed
at Applied Biosystems. Mr. Corcoran holds a BS degree in Computer
Science from California State University, Hayward. Profile
Mr. Corcoran: We have refocused the company in the last six
months to concentrate on transcript profiling, an area where we
use our
